covid19

About Covid-19 Vaccine: Frequently Asked Inquiries

It is advisable that the same mRNA vaccine product be utilised for all doses in the main series. These updated COVID-19 vaccines present additional protection from the BA.4 and BA.5 lineages of the Omicron variant of the virus as well as the original strain. This vaccine is accessible beneath an emergency use authorization. In clinical trials, this vaccine was 66% efficient in preventing the COVID-19 virus with symptoms — as of 14 days immediately after vaccination. COVAX is co-led by the Coalition for Epidemic Preparedness Innovations , Gavi and WHO, with UNICEF as a key delivery partner and PAHO as...